Cholestatic patients undergoing surgery have increased mortality and demonstrate clinical features suggestive of adrenal insufficiency. To examine whether cholestasis influences the status of the hypothalamic-pituitary-adrenal axis, we evaluated rats with acute cholestasis caused by bile duct resection (BDR) and sham-operated and unoperated controls. Basal unstressed plasma concentrations of AC`TH and corticosterone were similar in BDR and sham-operated and unoperated control rats. However, exposure of BDR rats to saturated ether vapor resulted in significantly less ACTH and corticosterone release in plasma than in the control animals. To understand the mechanism(s) of decreased HPA axis responsiveness to ether stress in cholestasis, we administered corticotropin-releasing factor (CRF) and measured hypothalamic content, mRNA levels and in vitro secretion of CRF and arginine vasopressin (AVP), the two principal secretagogues of ACTH. In BDR animals, ACTH responses to CRF were decreased and hypothalamic content of CRF and CRF mRNA expression in the paraventricular nucleus were decreased by 25 and 37%, respectively. Furthermore, CRF release from hypothalamic explants of BDR rats was 23% less than that ofcontrols. In contrast to CRF, hypothalamic content of AVP was 35% higher, AVP mRNA in the paraventricular nucleus was increased by 6.6-fold, and hypothalamic explant release of AVP was 24% higher in BDR rats than in control animals. Pituitary ACTH contents were similar in BDR and sham resected rats, but higher than unoperated controls. These findings demonstrate that acute cholestasis in the rat is associated with suppression of hypothalamic-pituitaryadrenal axis responsiveness to stress and demonstrate a dissociation between mechanisms of ACTH regulation mediated by
Introduction
Increased perioperative morbidity and mortality are well recognized in patients with cholestasis, and are associated with hypovolemia, hypotension, and renal failure (1) (2) (3) . These complications of cholestasis resemble the clinical features of adrenal insufficiency (4) . In addition, in provocative stress testing, 25% of alcoholic cirrhotics have been shown to have impaired responsiveness of the hypothalamic-pituitary-adrenal (HPA)' axis (5) . It seemed possible, therefore, that hyporesponsiveness of the HPA axis might contribute to the apparently enhanced vulnerability of cholestatic patients to surgical stress. Obstructive jaundice in humans and animals has been associated with the accumulation in plasma of a number of substances, which are known to interact with the HPA axis, including cytokines (6, 7) and endogenous opioids (8, 9) , and which may influence the basal or stress related activity of this axis.
Hypothalamic corticotropin-releasing factor (CRF), produced by the median division of the paraventricular nucleus (PVN), has been shown to be the principal, permissive regulator of ACTH secretion from the anterior pituitary (10) . Arginine vasopressin (AVP), produced by parvocellular neurons of the PVN and from collaterals of magnocellular neurons terminating in the median eminence, is also a major coregulator of pituitary ACTH secretion. AVP acts synergistically with CRF to augment ACTH release ( 11) . Based on observations made in cholestatic patients undergoing surgery, we postulated that cholestatic rats may have reduced responsiveness of the HPA axis to stress. To test this hypothesis, we studied the basal status ofthe HPA axis and its responsiveness to ether stress in the bile duct-resected (BDR) rat model of cholestasis and parallel sham-resected and unoperated controls. We documented a diminished responsiveness of the HPA axis to acute stress in BDR animals.
Methods
Animals. Male Sprague-Dawley rats weighing 190-210 g were obtained from Taconic Farms Inc., (Germantown, NY). All animals were housed two per cage in a light controlled room maintained at 22°C with a 12-h day/night cycle and were given free access to food and water. The rats were handled regularly.
Model ofacute cholestasis. Laparotomy was performed under general anesthesia induced by intraperitoneal injection of ketamine HCl (50 mg/ml) (Parke-Davis, Morris Plains, NJ) and xylazine (100 mg/ ml) (Fermenta Animal Health Co., Kansas City, MO), 8:1, vol/vol, dose 0.2-0.3 ml/rat. The bile duct was isolated, doubly ligated, and resected between the ligatures as described by Cameron and Oakley ( 12) . Sham resection consisted of laparotomy and bile duct identification and manipulation without ligation or resection. Unoperated agematched rats also served as controls. Experiments were performed 5 d after surgery.
Model ofstress. To activate the HPA axis and stimulate ACTH and corticosterone release, rats were exposed to saturated ether vapor, a 1. Abbreviations used in this paper: AVP, arginine vasopressin; BDR, bile duct resected; CRF, corticotropin-releasing factor; HPA, hypothalamic-pituitary-adrenal; PVN, paraventricular nucleus; SCN, suprachiasmatic; SON, supraoptic.
well-described systemic stressor, for 1 min. Ether vapor has been shown to activate the HPA axis in part by stimulating CRF release from the hypothalamus ( 13) .
Ovine CRF administration. To examine the responsiveness of the corticotroph to CRF, we administered ovine CRF intraperitoneally to bile duct-resected and sham-resected rats (2.0 gg/200 g in 0.5 ml normal saline) (Peninsula Labs, Inc., Belmont, CA) and measured truncal blood ACTH levels 30 min later.
Blood and tissue samples. All rats were killed by decapitation between 9:00 a.m. and 11:00 a.m. to obviate effects of the circadian rhythm of ACTH and corticosterone levels on the results. Rats were killed within 30 s after removal from their cage for the determination of basal hormone levels in the unstressed state, and 2 and 20 min after exposure to ether vapor for the determination of plasma ACTH and corticosterone levels, respectively; i.e. when the respective plasma levels are maximal (Swain, M. G., unpublished observation) ( 14) . Truncal blood was collected into prechilled EDTA-containing plastic tubes for ACTH and corticosterone determination. Blood samples were centrifuged immediately at 1,000 g for 12 min and plasma was stored at -70'C until assayed.
Adrenal glands were removed, trimmed free from fat, and weighed. Pituitary glands were rapidly removed from the skull, the anterior pituitary was separated, placed in a plastic tube on ice, and immediately frozen at -70'C. It was subsequently homogenized in 500 ,l 0.1 N HCO and the homogenate was lyophilized.
Hypothalami were dissected out on ice. The tissue blocks were defined rostrally by the posterior border ofthe optic chiasm, caudally by the anterior border ofthe mammillary bodies, laterally by the hypothalamic fissures, dorsally by the roof ofthe third ventricle, and ventrally by the stalk-sectioned infundibulum. To determine total hypothalamic CRF and AVP concentrations, hypothalami were extracted and homogenized in 1.0 ml of ice-cold 0.1 N HCl and centrifuged for 20 min at 3,000 g at 4VC. Supernatants were lyophylized and stored at -70'C until assayed for CRF/AVP contents.
For the determination of hypothalamic basal CRF release in vitro, hypothalamic organ explants were collected in ice-cold Medium 199 with modified Earle's salt (Gibco Laboratories, Grand Island, NY) containing 0.1% BSA, 100 KIU/ml aprotinin, 20 Radioimmunoassay of CRF was performed as described previously, using a specific anti-CRF serum developed in our laboratory (15 ACTH levels in sham-resected and unoperated control animals, respectively (P < .01; Fig. 1 ). These ether-induced elevations of plasma ACTH levels were accompanied by elevations in plasma corticosterone levels. After exposure to ether, plasma corticosterone levels rose 11.2-fold and 7.9-fold in unoperated control and sham-resected rats, respectively. The poststress absolute plasma corticosterone levels in these groups were similar (497±30.5 ng/ml vs 477±52.1 ng/ml, P = NS; Fig. 2 ). In contrast, in BDR animals, post-ether stress plasma corticosterone levels were increased only fivefold and these levels were significantly less than in the other two groups (P < .01; Fig. 2 ). Ovine CRF administration. Plasma ACTH levels determined in truncal blood 30 min after the administration of ovine CRF were significantly lower in BDR animals than in sham-resected controls (BDR: 531.5±36.5 pg/ml vs sham-resected: 729.8±57.0 pg/ml; n = 8; P < .005).
Hypothalamic CRF and A VP content and basal release.
Values for hypothalamic CRF content were similar in unoperated control and sham-operated rats and were significantly higher than those for BDR rats (BDR: *93.2±6.7 pg/mg pro- 16 and 35% less than that for unoperated controls, respectively (P < ;05 and P < .01, respectively) (Fig. 5 ) . In addition, basal CRF release was significantly lower in BDR than in sham-operated animals (BDR: 23.3±1.8 pg/ml vs sham operated: 30.4±1.7 pg/ml; P < .01; (Fig. 5) . Values for the in vitro release of AVP from hypothalamic explants from unoperated control and sham-resected animals were similar ( Fig. 6 , P = NS). However, in contrast to the CRF data, basal hypothalamic secretion ofAVP was about 24% higher in BDR animals than in unoperated and sham-resected controls (BDR: *143.8±7.1 pg/ml media; sham-resected controls: 115.7±6.9 pg/ml media; unoperated controls: 102.8±3.8 pg/ml media; [ Fig. 6 985±94.6 mg protein/pituitary, n = 8 per group, P = NS).
Values for pituitary ACTH content in both sham-resected and BDR rats were similar and were higher than those for unoperated control animals (BDR: 260±28.1 ng/mg protein; sham resected: 247±26.0 ng/mg protein; unoperated control: 159±16.5 ng/mg protein [ Fig. 9 ] P < .01 for both groups vs unoperated controls).
Discussion
The results ofthis study demonstrate that in rats with unequivocal acute cholestasis there is a significant suppression of the responsiveness of the HPA axis to stress. In the absence of exogenous stress, however, baseline plasma ACTH and total corticosterone levels in BDR rats were similar to those in shamoperated and unoperated control rats. These findings are consistent with the normal adrenal weights of BDR animals and with the normal basal plasma levels ofACTH and cortisol documented in humans with liver diseases (20) . Our results contrast with results from studies in rats using chronic stress paradigms, such as chronic exposure to cold or recurrent restraint, in which, after several days of exposure to stress, basal plasma corticosterone levels and adrenal weights were higher than those of unstressed control rats (21, 22) .
The increase in plasma ACTH after exposure to saturated ether vapor, a well-described systemic stressor in rats ( 13) (21 ) . Thus, the diminished hypothalamic CRF content in BDR rats does not appear to be attributable to chronic stress per se. Furthermore, the finding ofsimilar hypothalamic CRF contents in sham-operated and unoperated control animals indicate that reduced hypothalamic CRF content in BDR rats is not the consequence of laparotomy alone, but is probably directly related to the cholestatic syndrome. The decrease in hypothalamic CRF content in BDR rats was paralleled by a striking reduction in hypothalamic CRF mRNA levels in these animals and by a decrease in hypothalamic CRF release in vitro. These findings suggest that diminished hypothalamic CRF content and secretion in BDR rats may be caused by a lesion at the transcriptional level.
In contrast to the hypothalamic CRF findings, BDR rats demonstrated enhanced hypothalamic AVP content, release, and mRNA expression. The increase in hypothalamic AVP content appears to be secondary to enhanced AVP gene expression in the PVN. AVP neurons from the PVN and SON both project to the posterior pituitary and release AVP into the systemic circulation in response to osmotic stimuli (24) . Dehydration has been shown to result in enhanced AVP gene expression in both the PVN and SON (25) . However, in BDR rats AVP mRNA expression was increased only in the parvocellular component of the PVN, suggesting that the abnormal mRNA expression is not related to dehydration. Consistent with this finding is the recent description of normal plasma AVP levels in rats 5 d after BDR (26) . Therefore, increased hypothalamic AVP mRNA content and secretion may occur as a homeostatic compensatory mechanism to the suppressed hypothalamic CRF release in cholestasis. Indeed, exogenous administration of ovine CRF demonstrated diminished corticotroph responsiveness in BDR rats compatible with decreased CRF priming of corticotrophs in BDR animals. In further support of this hypothesis is the recent report that increased AVP secretion from the hypothalamus stimulates more corticotrophs in the anterior pituitary to secrete ACTH, whereas increasing concentrations of CRF stimulate more ACTH secretion per cell (27) .
We have previously documented a striking elevation of plasma endogenous opioid activity in BDR rats (9) . Opioid peptides are known to suppress hypothalamic CRF secretion in vitro (28) and exposure of rats to morphine for 5 d reduces the capacity of the hypothalamus to secrete CRF (29) . We have demonstrated that BDR rats exhibit decreased basal CRF release from hypothalamic explants in vitro, suggesting that there is a lesion at the hypothalamic level in cholestasis. Whether, and to what extent, this is related to the marked increase in plasma opioid activity documented in this model ofcholestasis is currently unknown.
A number of cytokines are known to acutely interact with and stimulate the HPA axis (30) (31) (32) . Recently, in rats with adjuvant-induced arthritis, mild chronic hypercorticosteronism was associated with diminished hypothalamic CRF release and CRF mRNA expression in the hypothalamus, as well as enhanced AVP mRNA expression and release from the hypothalamus (33) . Adjuvant treated arthritic animals would be expected to have elevated circulating inflammatory cytokines such as TNF-alpha, IL-1 and IL-6. Increased levels of plasma cytokines have been documented in cholestatic patients (7) and BDR mice (6) . Chronically elevated levels of cytokines have been associated with impairment in the activation of the HPA axis in states such as rheumatoid arthritis (34, 35) and sleeping sickness (36) . In addition, in patients with extensive burns, TNF-alpha levels in plasma correlate negatively with plasma cortisol concentrations (37). Therefore, elevated plasma cytokine levels may contribute to the abnormalities in hypothalamic CRF and AVP demonstrated in the BDR rat model of cholestasis.
In summary, we have documented a diminished plasma ACTH and corticosterone response in BDR rats exposed to a strong systemic stressor. This defect appears to be caused in part by decreased CRF synthesis and secretion from the hypothalamus. The observed suppression of hypothalamic CRF activity in BDR rats is associated with an enhancement of hypothalamic AVP synthesis and secretion. The results suggest that the responsiveness of the HPA axis during periods of maximal stress in cholestasis may be inadequate and may, therefore, contribute to the enhanced surgical morbidity and mortality documented in cholestatic patients.
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